We are live on ! Find out more
CCWM

Cassaday & Co Wealth Management Portfolio holdings

AUM $4.69B
1-Year Est. Return 20.56%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.56%
3 Year Est. Return
+61.95%
5 Year Est. Return
10 Year Est. Return
AUM
$3.18B
AUM Growth
+$104M
Cap. Flow
+$31.3M
Cap. Flow %
0.98%
Top 10 Hldgs %
77.68%
Holding
319
New
23
Increased
107
Reduced
107
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 3.38%
2 Consumer Discretionary 1.68%
3 Financials 1.01%
4 Consumer Staples 0.9%
5 Healthcare 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKE icon
76
Oneok
OKE
$57.2B
$1.59M 0.05%
19,472
-16
-0.1% -$1.28K
SHW icon
77
Sherwin-Williams
SHW
$82.7B
$1.55M 0.05%
5,189
+31
+0.6% +$9.59K
IBB icon
78
iShares Biotechnology ETF
IBB
$9.34B
$1.54M 0.05%
11,204
-13
-0.1% -$1.74K
VNQ icon
79
Vanguard Real Estate ETF
VNQ
$39.2B
$1.5M 0.05%
17,886
+2,879
+19% +$238K
UPV icon
80
ProShares Ultra FTSE Europe
UPV
$17M
$1.5M 0.05%
24,060
VSS icon
81
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$1.48M 0.05%
12,599
+910
+8% +$107K
D icon
82
Dominion Energy
D
$60.8B
$1.47M 0.05%
29,960
-536
-2% -$27.3K
COF icon
83
Capital One
COF
$128B
$1.45M 0.05%
10,441
+1,791
+21% +$251K
CSCO icon
84
Cisco
CSCO
$457B
$1.27M 0.04%
26,660
-741
-3% -$35.2K
OXM icon
85
Oxford Industries
OXM
$566M
$1.26M 0.04%
12,573
-33,587
-73% -$3.54M
ADBE icon
86
Adobe
ADBE
$99.5B
$1.25M 0.04%
2,249
+4
+0.2% +$1.94K
TMO icon
87
Thermo Fisher Scientific
TMO
$213B
$1.2M 0.04%
2,178
-32
-1% -$18.3K
QLD icon
88
ProShares Ultra QQQ
QLD
$12.7B
$1.17M 0.04%
23,378
+3,124
+15% +$139K
AMGN icon
89
Amgen
AMGN
$208B
$1.17M 0.04%
3,734
+53
+1% +$15.6K
ZROZ icon
90
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
$1.14M 0.04%
15,225
ACWX icon
91
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$1.14M 0.04%
21,447
DHR icon
92
Danaher
DHR
$137B
$1.1M 0.03%
4,384
+8
+0.2% +$2.02K
HON icon
93
Honeywell
HON
$77B
$1.09M 0.03%
5,437
+17
+0.3% +$3.23K
VGT icon
94
Vanguard Information Technology ETF
VGT
$139B
$1.04M 0.03%
14,496
-616
-4% -$41K
GLD icon
95
SPDR Gold Trust
GLD
$131B
$1.04M 0.03%
4,847
DDM icon
96
ProShares Ultra Dow30
DDM
$542M
$1.03M 0.03%
24,898
ACN icon
97
Accenture
ACN
$102B
$1.01M 0.03%
3,325
-515
-13% -$158K
PFE icon
98
Pfizer
PFE
$143B
$1M 0.03%
35,918
-3,891
-10% -$107K
MDY icon
99
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$1M 0.03%
1,871
NEE icon
100
NextEra Energy
NEE
$181B
$994K 0.03%
14,044
+39
+0.3% +$2.77K

Similar funds

Cassaday & Co Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Cassaday & Co Wealth Management held 319 positions worth $3.18B, up 3.4% from $3.08B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Cassaday & Co Wealth Management's Q2 2024 filing shows 23 new, 107 increased, 107 reduced and 29 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 1,330 shares worth $520K. The largest sale was Oxford Industries, an estimated $3.54M.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 2.9% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Cassaday & Co Wealth Management's largest Q2 2024 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 1,330 shares worth $520K.
  • Cassaday & Co Wealth Management added most to iShares Russell 2000 Growth ETF in Q2 2024, an estimated $4.56M increase.
  • Cassaday & Co Wealth Management's biggest Q2 2024 reduction was Oxford Industries, cutting an estimated $3.54M.
  • Cassaday & Co Wealth Management fully exited Morgan Stanley in Q2 2024, selling an estimated $324K.
  • Cassaday & Co Wealth Management's ten largest holdings make up 78% of its $3.18B portfolio in Q2 2024.
  • Cassaday & Co Wealth Management opened 23 new positions and closed 29 in Q2 2024.
  • Cassaday & Co Wealth Management's portfolio value rose 3.4% quarter-over-quarter to $3.18B.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2024, filed 30 Jul 2024.